Interactions and relevance of blast percentage and treatment strategy among younger and older patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)

Lignende værker

• Intensive Chemotherapy (IC) is More Effective than Hypomethylating Agents (HMA) for the Treatment of Younger Patients with Myelodysplastic Syndrome (MDS) and Elevated Bone Marrow Blasts
  af: Strati, Paolo, et al.
  Udgivet: (2019)
• The Heterogeneous Prognosis Of Patients With Myelodysplastic Syndrome (MDS) And Chromosome 5 Abnormalities: How Does It Relate To The Original Lenalidomide Experience in MDS?
  af: Kantarjian, Hagop, et al.
  Udgivet: (2009)
• CD33 is frequently expressed in cases of myelodysplastic syndrome and chronic myelomonocytic leukemia with elevated blast count
  af: Sanford, David, et al.
  Udgivet: (2016)
• IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
  af: DiNardo, Courtney D, et al.
  Udgivet: (2015)
• Retrospective Analysis of Prognostic Factors Associated With Response and Overall Survival by Baseline Marrow Blast Percentage in Patients With Myelodysplastic Syndromes Treated With Decitabine
  af: Jabbour, Elias, et al.
  Udgivet: (2013)